에이프로젠바이오로직스: management transactions · South Korea · DART (FSS)

Browse the full directors' dealings record of 에이프로젠바이오로직스, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €102.5bn. The latest transaction was filed on 8 May 2026 (Sale). Among the most active insiders: 에이프로젠. All data is accessible without an account.